O. Khaleva

发表

How many patients need cardiac resynchronization therapy?

J. Cleland, K. Goode, O. Khaleva, 2006, European heart journal.

Should patients who have persistent severe symptoms receive a left ventricular assist device or cardiac resynchronization therapy as the next step?

J. Cleland, A. Clark, Ahmed Tageldien, 2007, Heart failure clinics.

Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure.

J. Cleland, J. Dubois-Randé, C. Lewinter, 2012, Journal of cardiac failure.

Revisiting a classical clinical sign: jugular venous ultrasound.

John G F Cleland, Andrew L Clark, J. Cleland, 2014, International journal of cardiology.

Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?

J. Cleland, A. Clark, Jufen Zhang, 2013, The International Journal of Cardiovascular Imaging.

Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure

J. Cleland, A. Clark, A. Coletta, 2007, European journal of heart failure.

Cardiac resynchronization therapy: dyssynchrony imaging from a heart failure perspective

J. Cleland, D. Cullington, Ahmed Tageldien, 2008, Current opinion in cardiology.

The Prevalence of Extra-cranial Carotid Artery Disease in Chronic Heart Failure

J. Cleland, A. Clark, Jufen Zhang, 2015 .

Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction

A. Rigby, J. Cleland, A. Clark, 2005, Heart.

Revisiting a classical clinical sign: jugular venous ultrasound.

J. Cleland, A. Clark, Jufen Zhang, 2014, International journal of cardiology.